Supplement: Shire Pharmaceuticals: A Study in Exponential Growth

Shire Pharmaceuticals: A Study in Exponential Growth By Charles Q. Choi RELATED ARTICLES Successful Strategies Margaret Foti: Devoted to cancer research The Launch and the Exit Entrepreneurs Boldly Break New Ground Mark Tykocinski: Open doors lead a scientist to his calling Many Happy Returns: Cephalon celebrates its 20th year Creative Collaboration It's not every company that can go from $7 million in revenues to more than $1.7 billion

Written byCharles Q. Choi
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Successful Strategies

Margaret Foti: Devoted to cancer research

The Launch and the Exit

Entrepreneurs Boldly Break New Ground

Mark Tykocinski: Open doors lead a scientist to his calling

Many Happy Returns: Cephalon celebrates its 20th year

Creative Collaboration

It's not every company that can go from $7 million in revenues to more than $1.7 billion in 10 years, but that's precisely what Shire Pharmaceuticals, whose hub lies in Wayne, Pa., accomplished in the last decade. The key to its success? Seizing opportunities that Big Pharma ignored.

Shire was founded in England in 1986 with just four employees. The company has gone from 540 employees in 1997 to roughly 3,400 now in 12 countries. Shire's rapid growth was driven by a strategy of mergers and acquisitions, with eight in the last 10 years. This strategy is focused on making Shire the leading specialty pharmaceuticals company.

"We consistently focus on relatively ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies